Complete Filing Data
Ping An Biomedical Co., Ltd. reported Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents of $36.70 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Ping An Biomedical Co., Ltd. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Selling And Marketing Expense | $300.0K | $306.6K | $332.5K |
| Revenues | $34.1M | $87.6M | $82.6M |
| Other Nonoperating Income | $42.0K | $110.4K | $1.0M |
| Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax | $134.1K | -$269.8K | -$138.5K |
| Operating Income Loss | -$14.7M | -$2.0K | $612.5K |
| Operating Expenses | $15.7M | $5.4M | $3.6M |
| Nonoperating Income Expense | $2.3K | -$680.7K | -$570.8K |
| Interest Expense Nonoperating | $307.1K | $705.3K | $1.7M |
| Income Tax Expense Benefit | $1.9M | -$601.5K | -$1.0M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$2.1M | -$682.7K | $41.7K |
| Gross Profit | $133.4K | $5.4M | $4.2M |
| General And Administrative Expense | $843.9K | $5.0M | $3.3M |
| Current Income Tax Expense Benefit | $46.1K | -$593.2K | -$1.0M |
| Cost Of Revenue | $33.2M | $82.2M | $78.3M |
| Comprehensive Income Net Of Tax | -$13.8M | -$1.0M | -$855.4K |
| Deferred Income Tax Assets Net | $4.2M | $2.7M | |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$954.3K | $269.8K | $138.5K |
| Deferred Income Tax Benefit Expense | $1.5M | -$8.3K | $7.5K |
| Net Income Loss | -$1.8M | -$1.3M | -$993.9K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $36.7M | $18.4K | $591.9K | $1.2M |
| Stockholders Equity | $45.2M | -$7.2M | -$5.9M | $4.6M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $5.2M | -$458.7K | -$575.7K | |
| Cash And Cash Equivalents At Carrying Value | $164.7K | $130.9K | $591.9K | |
| Retained Earnings Accumulated Deficit | -$21.0M | -$8.2M | ||
| Prepaid Expense And Other Assets Current | $1.4M | $12.6M | ||
| Operating Lease Right Of Use Asset | $467.6K | $811.8K | ||
| Operating Lease Liability Noncurrent | $95.7K | $461.5K | ||
| Operating Lease Liability Current | $371.9K | $350.4K | ||
| Liabilities Noncurrent | $95.7K | $461.5K | ||
| Liabilities Current | $23.1M | $63.6M | ||
| Liabilities And Stockholders Equity | $9.6M | $56.8M | ||
| Liabilities | $3.3M | $64.0M | ||
| Inventory Net | $62.1K | $127.3K | ||
| Contract With Customer Liability Current | $69.8K | $1.7M | ||
| Common Stock Value | $8.4K | $7.3K | ||
| Assets Noncurrent | $662.6K | $3.5M | ||
| Assets Current | $63.7M | $53.3M | ||
| Assets | $68.4M | $56.8M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$226.3K | -$656.7K | ||
| Accounts Receivable Net Current | $16.9M | $40.4M | ||
| Accounts Payable Current | $1.3M | $15.1M | ||
| Accounts Payable And Other Accrued Liabilities Current | $287.7K | $608.0K | ||
| Repayments Of Short Term Debt | $1.4M | $48.1M | $35.5M | |
| Repayments Of Related Party Debt | $85.4M | $35.0M | $28.3M | |
| Property Plant And Equipment Net | $5.6K | |||
| Deferred Income Expense Benefit | -$214.5K | $8.3K | -$7.5K | |
| Right Of Use Asset Obtained In Exchange For Finance Lease Liability | $1.1M | $773.8K | ||
| Provision For Inventory Obsolescence | -$6.1K | $6.1K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $1.1M | $1.1M | $5.9M |
| Increase Decrease In Inventories | $308.5K | -$3.1M | -$1.4M |
| Increase Decrease In Contract With Customer Liability | -$1.6M | $1.1M | $258.7K |
| Increase Decrease In Accrued Income Taxes Payable | -$46.1K | $328.3K | -$1.1M |
| Increase Decrease In Accounts Receivable | -$14.2M | -$6.5M | -$9.9M |
| Increase Decrease In Accounts Payable And Other Operating Liabilities | -$45.5K | -$252.7K | -$930.0K |
| Increase Decrease In Accounts Payable | -$5.6M | $5.8M | -$8.8M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$93.7K | -$2.3K | $1.1K |
| Net Cash Provided By Used In Investing Activities | $0.00 | $15.0M | -$3.4M |
| Proceeds From Short Term Debt | $1.4M | $15.6M | $42.5M |
| Increase Decrease In Due From Related Parties | -$1.1K | -$3.7K | |
| Increase Decrease In Advance From Related Parties | $388.9K | $290.1K | |
| Proceeds From Related Party Debt | $51.9M | $37.8M | $39.7M |
| Increase Decrease In Repayment Of Obligation Under Operating Leases | -$50.5K | -$353.1K | -$384.0K |
| Net Cash Provided By Used In Operating Activities | -$6.4M | $14.6M | -$6.1M |
| Net Cash Provided By Used In Financing Activities | $43.7M | -$30.1M | $8.9M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Earnings Per Share Diluted | $-0.69 | $-0.07 | $-0.06 |
| Earnings Per Share Basic | $-0.69 | $-0.07 | $-0.06 |
| Weighted Average Number Of Shares Outstanding Basic | 18.5M | 18.0M | 18.0M |
| Weighted Average Number Of Diluted Shares Outstanding | 18.5M | 18.0M | 18.0M |
| Common Stock Shares Outstanding | 20.5M | 18.0M | |
| Common Stock Shares Issued | 20.5M | 18.0M | |
| Common Stock Shares Authorized | 800.0M | 800.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Other Noncash Expense | $50.5K | $353.1K | $384.0K |
| Investment Income Interest | $45.8K | $2.0K | $156.1K |
| Interest Paid Net | $310.9K | $705.3K | $2.0M |
| Statutory Accounting Practices Statutory Capital And Surplus Balance | $235.9K | $1.7M | |
| Short Term Borrowings | $10.0M | $10.0M | |
| Provision For Other Credit Losses | $9.3M | $124.0K | $29.8K |
| Provision For Doubtful Accounts | $1.3M | $119.9K | $29.8K |
| Depreciation | $785.00 | $10.2K | $32.8K |
Most recent annual filing with the SEC: January 30, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.